STALLION URANIUM CORP (STUD.CA) Fundamental Analysis & Valuation

TSX-V:STUD • CA8529192087

Current stock price

0.32 CAD
0 (0%)
Last:

This STUD.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. STUD.CA Profitability Analysis

1.1 Basic Checks

  • STUD had negative earnings in the past year.
  • In the past year STUD has reported a negative cash flow from operations.
  • STUD had negative earnings in each of the past 5 years.
  • In the past 5 years STUD always reported negative operating cash flow.
STUD.CA Yearly Net Income VS EBIT VS OCF VS FCFSTUD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

  • The Return On Assets of STUD (-53.67%) is worse than 79.43% of its industry peers.
  • STUD has a worse Return On Equity (-54.65%) than 68.90% of its industry peers.
Industry RankSector Rank
ROA -53.67%
ROE -54.65%
ROIC N/A
ROA(3y)-61.91%
ROA(5y)-42.67%
ROE(3y)-74.25%
ROE(5y)-51.05%
ROIC(3y)N/A
ROIC(5y)N/A
STUD.CA Yearly ROA, ROE, ROICSTUD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

  • STUD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STUD.CA Yearly Profit, Operating, Gross MarginsSTUD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. STUD.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for STUD has been increased compared to 1 year ago.
  • STUD has more shares outstanding than it did 5 years ago.
  • STUD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
STUD.CA Yearly Shares OutstandingSTUD.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
STUD.CA Yearly Total Debt VS Total AssetsSTUD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • STUD has an Altman-Z score of 54.54. This indicates that STUD is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of STUD (54.54) is better than 97.13% of its industry peers.
  • STUD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 54.54
ROIC/WACCN/A
WACCN/A
STUD.CA Yearly LT Debt VS Equity VS FCFSTUD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • A Current Ratio of 35.69 indicates that STUD has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 35.69, STUD belongs to the best of the industry, outperforming 99.04% of the companies in the same industry.
  • A Quick Ratio of 35.69 indicates that STUD has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 35.69, STUD belongs to the best of the industry, outperforming 99.04% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 35.69
Quick Ratio 35.69
STUD.CA Yearly Current Assets VS Current LiabilitesSTUD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. STUD.CA Growth Analysis

3.1 Past

  • STUD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -298.26%.
EPS 1Y (TTM)-298.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%171.92%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. STUD.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • STUD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STUD.CA Price Earnings VS Forward Price EarningsSTUD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STUD.CA Per share dataSTUD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. STUD.CA Dividend Analysis

5.1 Amount

  • No dividends for STUD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

STUD.CA Fundamentals: All Metrics, Ratios and Statistics

STALLION URANIUM CORP

TSX-V:STUD (3/19/2026, 7:00:00 PM)

0.32

0 (0%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-27
Earnings (Next)05-21
Inst Owners1.5%
Inst Owner ChangeN/A
Ins Owners17.03%
Ins Owner ChangeN/A
Market Cap47.41M
Revenue(TTM)N/A
Net Income(TTM)-15.40M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.68
P/tB 1.68
EV/EBITDA N/A
EPS(TTM)-0.53
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.19
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -53.67%
ROE -54.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-61.91%
ROA(5y)-42.67%
ROE(3y)-74.25%
ROE(5y)-51.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 35.69
Quick Ratio 35.69
Altman-Z 54.54
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-298.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%171.92%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y23.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.02%
OCF growth 3YN/A
OCF growth 5YN/A

STALLION URANIUM CORP / STUD.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of STALLION URANIUM CORP (STUD.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to STUD.CA.


What is the valuation status of STALLION URANIUM CORP (STUD.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to STALLION URANIUM CORP (STUD.CA). This can be considered as Overvalued.


Can you provide the profitability details for STALLION URANIUM CORP?

STALLION URANIUM CORP (STUD.CA) has a profitability rating of 0 / 10.